BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 86-91

  Ladenstein, R ^a,e   Peters, C ^a   Matthes Martin, S ^a   Rosenmayr, A ^b   Hocker P ^c   Potter R ^d   Potschinger U ^a   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Austrian Bone Marrow Donor Registry   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Clinic for Radiotherapy and Radiobiology   (Austria)

^e StAnna Kinderspital ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; PREDNISOLONE; PSORALEN; THALIDOMIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HLA MATCHING; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALE; ORGAN DONOR; PRIORITY JOURNAL; PUVA; SIBLING; STATISTICAL ANALYSIS; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA; MALE; MIDDLE AGED; NUCLEAR FAMILY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029827158     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. New England J Med 1985; 313: 765-771.
2. Ash RC, Horowitz MM, Gale RP, et al: Bone marrow transplantation from related donors other than HLA-identical siblings. Effect of T-cell depletion. Bone marrow transplantation 1991; 7: 443-452.
3. Beatty PG, Hansen JA, Longton GM, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematological malignancies. Transplantation 1991; 51: 443-447.
4. Cox DR. Regression models and life tables. Journal of the Royal Statistical Society B. 1972; 34: 187-220.
5. Hows J, Bradley BA, Gore S et al. Propective evaluation of unrelated donor bone marrow transplantation. Bone marrow transplantation 1993; 12: 371-380.
6. Kernan NA, Bartsch G, Ash RC, at al: Analysis of 462 transplantation from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 593-602.